Arrowhead Research reported $3.5B in Market Capitalization this January of 2023, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Agios Pharmaceuticals AGIO:US USD 1.55B 335M
Alnylam Pharmaceuticals ALNY:US USD 24.62B 6.97B
Anika Therapeutics ANIK:US USD 348M 23M
Arrowhead Research ARWR:US USD 3.5B 225M
Bluebird Bio BLUE:US USD 488M 192M
Heron Therapeutics HRTX:US USD 501M 215M
Intercept Pharmaceuticals ICPT:US USD 574M 164M
Ligand Pharmaceuticals LGND:US USD 1.45B 50M
Merk MRK:US USD 218.17B 12.39B
Mirati Therapeutics MRTX:US USD 3.88B 156M
Moderna Inc MRNA:US USD 46.26B 10.56B
Nektar Therapeutics NKTR:US USD 600M 108M
Novartis NOVN:VX USD 181.55B 12.79B
Opko Health OPK:US USD 1.46B 266M
Sarepta Therapeutics SRPT:US USD 9.68B 3.12B
Spectrum Pharmaceuticals SPPI:US USD 87M 57M
Tg Therapeutics TGTX:US USD 860M 246M
Ultragenyx Pharmaceutical RARE:US USD 2.9B 1.27B
Vertex Pharmaceuticals VRTX:US USD 74.3B 2.16B
Xencor XNCR:US USD 1.55B 79M
YTE INCY:US USD 14.82B 2.01B